- Preface
- Contributors
- Symbols and Abbreviations
- Classes of recommendations and levels of evidence
- Amendments and Updates
- Chapter 1.1 Hypertension
- Chapter 1.2 Dyslipidaemia
- Chapter 1.3 Metabolic syndrome and diabetes
- Chapter 1.4 Thrombosis
- Chapter 2.1 Acute coronary syndrome: STEMI and NSTEMI
- Chapter 2.2 Chronic stable angina
- Chapter 2.3 Coronary artery spasm and microvascular angina
- Chapter 2.4 Takotsubo syndrome
- Chapter 3.1 Heart failure
- Chapter 3.2 Heart transplantation
- Chapter 4.1 Atrial fibrillation
- Chapter 4.2 Supraventricular (narrow complex) tachycardias
- Chapter 4.3 Ventricular arrhythmias
- Chapter 4.4 Bradyarrhythmias
- Chapter 4.5 Syncope
- Chapter 5.1 Valvular heart disease
- Chapter 5.2 Myocarditis and pericardial syndromes
- Chapter 5.3 Cardiomyopathy
- Chapter 5.4 Pulmonary hypertension
- Chapter 6.1 Kidney disease
- Chapter 6.2 Pregnancy and lactation
- Chapter 6.3 Liver disease
- Chapter 7.1 Major drug interactions
- Chapter 8.1 Cardiovascular drugs—from A to Z
- Chapter 9.1 Non-cardiac drugs affecting the heart—from A to Z
- Index
(p. 165) Heart transplantation
- Chapter:
- (p. 165) Heart transplantation
- Author(s):
Finn Gustafsson
, and Kasper Rossing
- DOI:
- 10.1093/med/9780198759935.003.0010_update_001
Update:
Small amends throughout
Heart transplantation remains the treatment of choice for end-stage heart failure refractory to conventional treatment. Long-term outcome is excellent, and median survival currently exceeds 13 years. The main causes of death late after transplantation are cardiac allograft vasculopathy and cancer. Medical therapy after transplantation is complex, including immunosuppressive therapy to reduce the risk of graft rejection and prophylaxis against viral and protozoal infections, as well as adjunctive therapy to treat common comorbidities, for instance hypertension. Pharmacological therapy of comorbid conditions requires specific consideration to clinically important interactions with immunosuppressive drugs.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Preface
- Contributors
- Symbols and Abbreviations
- Classes of recommendations and levels of evidence
- Amendments and Updates
- Chapter 1.1 Hypertension
- Chapter 1.2 Dyslipidaemia
- Chapter 1.3 Metabolic syndrome and diabetes
- Chapter 1.4 Thrombosis
- Chapter 2.1 Acute coronary syndrome: STEMI and NSTEMI
- Chapter 2.2 Chronic stable angina
- Chapter 2.3 Coronary artery spasm and microvascular angina
- Chapter 2.4 Takotsubo syndrome
- Chapter 3.1 Heart failure
- Chapter 3.2 Heart transplantation
- Chapter 4.1 Atrial fibrillation
- Chapter 4.2 Supraventricular (narrow complex) tachycardias
- Chapter 4.3 Ventricular arrhythmias
- Chapter 4.4 Bradyarrhythmias
- Chapter 4.5 Syncope
- Chapter 5.1 Valvular heart disease
- Chapter 5.2 Myocarditis and pericardial syndromes
- Chapter 5.3 Cardiomyopathy
- Chapter 5.4 Pulmonary hypertension
- Chapter 6.1 Kidney disease
- Chapter 6.2 Pregnancy and lactation
- Chapter 6.3 Liver disease
- Chapter 7.1 Major drug interactions
- Chapter 8.1 Cardiovascular drugs—from A to Z
- Chapter 9.1 Non-cardiac drugs affecting the heart—from A to Z
- Index